Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 203

1.

CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.

Gibson SA, Yang W, Yan Z, Qin H, Benveniste EN.

J Immunol. 2018 Jul 15;201(2):383-392. doi: 10.4049/jimmunol.1701592. Epub 2018 Jun 11.

PMID:
29891553
2.

MicroRNA-31 is required for astrocyte specification.

Meares GP, Rajbhandari R, Gerigk M, Tien CL, Chang C, Fehling SC, Rowse A, Mulhern KC, Nair S, Gray GK, Berbari NF, Bredel M, Benveniste EN, Nozell SE.

Glia. 2018 May;66(5):987-998. doi: 10.1002/glia.23296. Epub 2018 Jan 30.

PMID:
29380422
3.

Protein Kinase CK2: An Emerging Regulator of Immunity.

Gibson SA, Benveniste EN.

Trends Immunol. 2018 Feb;39(2):82-85. doi: 10.1016/j.it.2017.12.002. Epub 2018 Jan 4.

PMID:
29307449
4.

Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease.

Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, Liu Y, Qin H, Benveniste EN, Standaert DG.

Exp Neurol. 2018 Feb;300:179-187. doi: 10.1016/j.expneurol.2017.11.010. Epub 2017 Nov 16.

PMID:
29155051
5.

Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.

Gibson SA, Yang W, Yan Z, Liu Y, Rowse AL, Weinmann AS, Qin H, Benveniste EN.

J Immunol. 2017 Jun 1;198(11):4244-4254. doi: 10.4049/jimmunol.1601912. Epub 2017 May 3.

6.

Speaking out about gender imbalance in invited speakers improves diversity.

Klein RS, Voskuhl R, Segal BM, Dittel BN, Lane TE, Bethea JR, Carson MJ, Colton C, Rosi S, Anderson A, Piccio L, Goverman JM, Benveniste EN, Brown MA, Tiwari-Woodruff SK, Harris TH, Cross AH.

Nat Immunol. 2017 Apr 18;18(5):475-478. doi: 10.1038/ni.3707. No abstract available.

7.

Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.

Rowse AL, Gibson SA, Meares GP, Rajbhandari R, Nozell SE, Dees KJ, Hjelmeland AB, McFarland BC, Benveniste EN.

J Neurooncol. 2017 Apr;132(2):219-229. doi: 10.1007/s11060-017-2378-z. Epub 2017 Feb 8.

8.

Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.

Lai YJ, Tsai JC, Tseng YT, Wu MS, Liu WS, Lam HI, Yu JH, Nozell SE, Benveniste EN.

Oncotarget. 2017 Mar 14;8(11):18031-18049. doi: 10.18632/oncotarget.14949.

9.

Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Zhao J, Yu H, Liu Y, Gibson SA, Yan Z, Xu X, Gaggar A, Li PK, Li C, Wei S, Benveniste EN, Qin H.

Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L868-L880. doi: 10.1152/ajplung.00281.2016. Epub 2016 Sep 16.

10.

Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.

Yan Z, Gibson SA, Buckley JA, Qin H, Benveniste EN.

Clin Immunol. 2018 Apr;189:4-13. doi: 10.1016/j.clim.2016.09.014. Epub 2016 Oct 3.

11.

Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.

Park KW, Lin CY, Benveniste EN, Lee YS.

Exp Neurol. 2016 Oct;284(Pt A):98-105. doi: 10.1016/j.expneurol.2016.08.002. Epub 2016 Aug 5.

12.

Correction: SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation.

Qin H, Holdbrooks AT, Liu Y, Reynolds SL, Yanagisawa LL, Benveniste EN.

J Immunol. 2016 Jul 1;197(1):387-9. doi: 10.4049/jimmunol.1600710. No abstract available.

13.

Attenuation of PKR-like ER Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-induced Inflammation Without Compromising Immunological Responses.

Guthrie LN, Abiraman K, Plyler ES, Sprenkle NT, Gibson SA, McFarland BC, Rajbhandari R, Rowse AL, Benveniste EN, Meares GP.

J Biol Chem. 2016 Jul 22;291(30):15830-40. doi: 10.1074/jbc.M116.738021. Epub 2016 May 23.

14.

Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.

Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd, Meares GP, Yu H, Yan Z, Harms AS, Li Y, Standaert DG, Benveniste EN.

J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.

15.

Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.

McFarland BC, Marks MP, Rowse AL, Fehling SC, Gerigk M, Qin H, Benveniste EN.

Oncotarget. 2016 Apr 12;7(15):20621-35. doi: 10.18632/oncotarget.7992.

16.

Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma.

Rajbhandari R, McFarland BC, Patel A, Gerigk M, Gray GK, Fehling SC, Bredel M, Berbari NF, Kim H, Marks MP, Meares GP, Sinha T, Chuang J, Benveniste EN, Nozell SE.

Oncotarget. 2015 Jul 10;6(19):17805-16.

17.

Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype.

Liu Y, Holdbrooks AT, Meares GP, Buckley JA, Benveniste EN, Qin H.

J Immunol. 2015 Aug 1;195(3):841-52. doi: 10.4049/jimmunol.1403063. Epub 2015 Jun 17.

18.

SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.

Yu H, Liu Y, McFarland BC, Deshane JS, Hurst DR, Ponnazhagan S, Benveniste EN, Qin H.

Cancer Immunol Res. 2015 Jul;3(7):727-40. doi: 10.1158/2326-6066.CIR-15-0004. Epub 2015 Feb 3.

19.

IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.

Basu R, Whitley SK, Bhaumik S, Zindl CL, Schoeb TR, Benveniste EN, Pear WS, Hatton RD, Weaver CT.

Nat Immunol. 2015 Mar;16(3):286-95. doi: 10.1038/ni.3099. Epub 2015 Feb 2.

20.

Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.

Liu Y, Gibson SA, Benveniste EN, Qin H.

Crit Rev Immunol. 2015;35(6):505-27. doi: 10.1615/CritRevImmunol.2016015517. Review.

Supplemental Content

Loading ...
Support Center